Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats

Behavioural Pharmacology

Volumn 21, Issue 4, 2010, Pages 359-368

  Der Avakian, Andre ^a   Markou, Athina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anhedonia; dependence; depression; motivation; psychostimulant; rat; reward

Indexed keywords

AMPHETAMINE; NICOTINE; SUCROSE; CENTRAL STIMULANT AGENT; NICOTINIC AGENT;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; LONG TERM EXPOSURE; MALE; MOTIVATION; NONHUMAN; RAT; REWARD; SOCIAL INTERACTION; WEIGHT GAIN; WEIGHT REDUCTION; ANIMAL; BODY WEIGHT; DEPRESSION; DRINKING; DRUG EFFECTS; EATING; HUMAN RELATION; INSTRUMENTAL CONDITIONING; PSYCHOLOGY; REINFORCEMENT; WISTAR RAT; WITHDRAWAL SYNDROME;

AMPHETAMINE; ANIMALS; BODY WEIGHT; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DEPRESSION; DRINKING; EATING; INTERPERSONAL RELATIONS; MALE; MOTIVATION; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, WISTAR; REINFORCEMENT SCHEDULE; REWARD; SUBSTANCE WITHDRAWAL SYNDROME; SUCROSE; WEIGHT GAIN;

EID: 77955176787     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32833c7cc8     Document Type: Article

References (52)

1. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders IV. Washington DC: American Psychiatric Press.
2. Barr AM, Phillips AG (1999). Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement. Psychopharmacology (Berl) 141:99-106.
3. Barr AM, Phillips AG (2002). Increased successive negative contrast in rats withdrawn from an escalating-dose schedule of D-amphetamine. Pharmacol Biochem Behav 71:293-299.
4. Barr AM, Markou A (2005). Psychostimulant withdrawal as an inducing condition in animal models of depression. Neurosci Biobehav Rev 29:675-706.
5. Barr AM, Fiorino DF, Phillips AG (1999). Effects of withdrawal from an escalating dose schedule of d-amphetamine on sexual behavior in the male rat. Pharmacol Biochem Behav 64:597-604.
6. Besheer J, Bevins RA (2003). Impact of nicotine withdrawal on novelty reward and related behaviors. Behav Neurosci 117:327-340.
7. Brady KT, Verduin ML, Tolliver BK (2007). Treatment of patients comorbid for addiction and other psychiatric disorders. Curr Psychiatry Rep 9:374-380.
8. Carroll ME, Lac ST (1987). Cocaine withdrawal produces behavioral disruptions in rats. Life Sci 40:2183-2190.
9. Cheeta S, Irvine EE, Kenny PJ, File SE (2001). The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology (Berl) 155:78-85.
10. Christianson JP, Paul ED, Irani M, Thompson BM, Kubala KH, Yirmiya R, et al. (2008). The role of prior stressor controllability and the dorsal raphe nucleus in sucrose preference and social exploration. Behav Brain Res 193:87-93.
11. Cryan JF, Hoyer D, Markou A (2003). Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol Psychiatry 54:49-58.
12. Dawkins L, Powell JH, Pickering A, Powell J, West R (2009). Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence. Addiction 104:850-858.
13. Epping-Jordan MP, Watkins SS, Koob GF, Markou A (1998). Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393:76-79.
14. File SE, Seth P (2003). A review of 25 years of the social interaction test. Eur J Pharmacol 463:35-53.
15. File SE, Zharkovsky A, Hitchcott PK (1992). Effects of nitrendipine, chlordiazep-oxide, flumazenil and baclofen on the increased anxiety resulting from alcohol withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 16:87-93.
16. Harris GC, Hummel M, Wimmer M, Mague SD, Aston-Jones G (2007). Elevations of FosB in the nucleus accumbens during forced cocaine abstinence correlate with divergent changes in reward function. Neuroscience. 147:583-591.
17. Harrison AA, Liem YT, Markou A (2001). Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropsychopharmacology. 25:55-71.
18. Hodos W (1961). Progressive ratio as a measure of reward strength. Science 134:943-944.
19. Irvine EE, Cheeta S, File SE (1999). Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav Pharmacol 10:691-697.
20. Irvine EE, Bagnalasta M, Marcon C, Motta C, Tessari M, File SE, et al. (2001a). Nicotine self-administration and withdrawal: modulation of anxiety in the social interaction test in rats. Psychopharmacology (Berl) 153:315-320.
21. Irvine EE, Cheeta S, Marshall M, File SE (2001b). Different treatment regimens and the development of tolerance to nicotine's anxiogenic effects. Pharmacol Biochem Behav 68:769-776.
22. Jonkman S, Henry B, Semenova S, Markou A (2005). Mild anxiogenic effects of nicotine withdrawal in mice. Eur J Pharmacol 516:40-45.
23. Kampman KM (2008). The search for medications to treat stimulant dependence. Addict Sci Clin Pract 4:28-35.
24. Kosten TR, Markou A, Koob GF (1998). Depression and stimulant dependence: neurobiology and pharmacotherapy. J Nerv Ment Dis 186:737-745.
25. Lago JA, Kosten TR (1994). Stimulant withdrawal. Addiction 89:1477-1481.
26. LeSage MG, Burroughs D, Pentel PR (2006). Effects of nicotine withdrawal on performance under a progressive-ratio schedule of sucrose pellet delivery in rats. Pharmacol Biochem Behav 83:585-591.
27. Leventhal AM, Kahler CW, Ray LA, Stone K, Young D, Chelminski I, et al. (2008). Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. Am J Addict 17:218-223.
28. Lin D, Koob GF, Markou A (1999). Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat-interactions between the two drugs. Psychopharmacology (Berl) 145:283-294.
29. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, et al. (2004). Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 61:73-84.
30. London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, et al. (2005). Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry 58:770-778.
31. Markou A, Koob GF (1991). Postcocaine anhedonia: an animal model of cocaine withdrawal. Neuropsychopharmacology 4:17-26.
32. Markou A, Kenny PJ (2002). Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories. Neurotox Res 4:297-313.
33. Markou A, Kosten TR, Koob GF (1998). Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharma-cology 18:135-174.
34. 1A receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats. Psychopharmacology (Berl) 178:133-142.
35. McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM (2005). The nature, time course and severity of methamphetamine withdrawal. Addiction 100:1320-1329.
36. Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS (2001). Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (ecstasy). Eur J Pharmacol 433:91-99.
37. Orsini C, Koob GF, Pulvirenti L (2001). Dopamine partial agonist reverses amphetamine withdrawal in rats. Neuropsychopharmacology 25:789-792.
38. Paterson NE, Myers C, Markou A (2000). Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. Psychopharmacology (Berl) 152:440-446.
39. Rawson RA, Huber A, Brethen P, Obert J, Gulati V, Shoptaw S, et al. (2002). Status of methamphetamine users 2-5 years after outpatient treatment. J Addict Dis 21:107-119.
40. Russig H, Pezze MA, Nanz-Bahr NI, Pryce CR, Feldon J, Murphy CA (2003). Amphetamine withdrawal does not produce a depressive-like state in rats as measured by three behavioral tests. Behav Pharmacol 14:1-18.
41. Russig H, Murphy CA, Feldon J (2005). Behavioural consequences of withdrawal from three different administration schedules of amphetamine. Behav Brain Res 165:26-35.
42. Schwabe K, Koch M (2007). Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats. Psychopharmacology (Berl) 191:759-765.
43. Short KR, Maier SF (1993). Stressor controllability, social interaction, and benzodiazepine systems. Pharmacol Biochem Behav 45:827-835.
44. Skjei KL, Markou A (2003). Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats. Psychopharmacology (Berl) 168: 280-292.
45. Sonntag H, Wittchen HU, Hofler M, Kessler RC, Stein MB (2000). Are social fears and DSM-IV social anxiety disorder associated with smoking and nicotine dependence in adolescents and young adults? Eur Psychiatry 15:67-74.
46. Suzuki T, Ise Y,Tsuda M, Maeda J, Misawa M (1996). Mecamylamine- precipitated nicotine-withdrawal aversion in rats. Eur J Pharmacol 314:281-284.
47. Trosclair A, Dube SR (2010). Smoking among adults reporting lifetime depression, anxiety, anxiety with depression, and major depressive episode, United States, 2005-2006. Addict Behav 35:438-443.
48. Vacca G, Phillips AG (2005). Inhibition of successive positive contrast in rats withdrawn from an escalating dose schedule of D-amphetamine. Int J Comp Psychol 18:298-306.
49. Vescovi PP, Coiro V, Volpi R, Passeri M (1992). Diurnal variations in plasma ACTH, cortisol and beta-endorphin levels in cocaine addicts. Horm Res 37:221-224.
50. Vuong SM, Oliver HA, Scholl JL, Oliver KM, Forster GL (2010). Increased anxietylike behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism. Behav Brain Res 208:278-281.
51. Watkins SS, Stinus L, Koob GF, Markou A (2000). Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther 292:1053-1064.
52. Zhang D, Zhou X, Wang X, Xiang X, Chen H, Hao W (2007). Morphine withdrawal decreases responding reinforced by sucrose self-administration in progressive ratio. Addict Biol 12:152-157.